Magnetic Resonance Imaging Captures Brain In Action

Neuroscience researchers have long wished for improved functional mapping of the brain--for the ability to create better images showing the brain in action, rather than just its structure. In the past, these researchers have depended mainly on positron emission tomography (PET), but safety concerns posed by the radioactive contrast agents involved, along with the relatively coarse resolution and slow speed of PET imaging, have limited the usefulness of their results. But now, a new, naturall

Written byFranklin Hoke
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

But now, a new, naturally occurring contrast agent that is used not with PET but with magnetic resonance imaging (MRI) is brightening prospects. Coupled with recently developed high-speed MRI techniques, this new agent is helping researchers create functional brain maps that display detail and sequential processes never before seen.

The newly found contrast agent is hemoglobin, present throughout the body. MRI researchers are taking advantage of the slight difference in magnetic properties between hemoglobin carrying oxygen and hemoglobin from which the oxygen has been stripped to generate their images. Oxygenated hemoglobin is diamagnetic, and deoxygenated hemoglobin is paramagnetic, meaning that oxyhemoglobin is weakly repelled and deoxyhemoglobin weakly attracted by a magnetic field. And, although experimental MRI instruments with high magnetic fields produce the best images based on the hemoglobin contrast, many commercially available clinical MRI machines are also capable of creating such images.

"A lot of what we're trying to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies